openPR Logo
Press release

GBS GBS in Canada Guillain Barre Syndrome in Canada Guillain Barre Syndrome

03-27-2018 03:12 PM CET | Health & Medicine

Press release from: GBSCIDP

GBS GBS in Canada Guillain Barre Syndrome in Canada Guillain

What is Guillain-Barre Syndrome (GBS)?
Guillain-Barré (Ghee-yan Bah-ray) Syndrome is an intemperate disorder of the incidental nerves outside the brain and spinal cord.
GBS also called:
1. Acute Incendiary Demyelinating Polyneuropathy
2. Landry’s Ascending Paralysis
GBS is indicate by the rapid onset of numbness, weakness, and often paralysis of the legs, arms, breathing muscles, and face. Deflation is climbing meaning that it movement up the extremity from fingers and toes towards the torso. Loss of reflexes, such as the knee jerk, are usually found.
What causes GBS?
The cause is unknown. We do know that about 50% of cases occur shortly after a microbial epidemic (viral or bacterial), some as simple and common as the flu or food poisoning. Some assumption offer an automate trigger, in which the patient’s defence structure of preventive and white blood cells are called into action against the body, damaging myelin (nerve covering or insulation), dominate to numbness and weakness.
How is GBS diagnosed?
To confirm a GBS diagnosis, two tests may be performed:
1. A lumbar puncture looking for elevated fluid protein
2. Electrical test of nerve and muscle function

GBS/CIDP Foundation of Canada is a registered Canadian charity. Our mission is that of support, education, research, and advocacy, and with the dedication of volunteers, no patient and their families, will go through one of these disorders alone.

PO Box 80060 RPO Rossland Garden Whitby, ON L1R 0H1

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GBS GBS in Canada Guillain Barre Syndrome in Canada Guillain Barre Syndrome here

News-ID: 994316 • Views:

More Releases for GBS

Guillain-Barre Syndrome (GBS) share, Analysis, Growth, Future Outlook | 2025-203 …
Guillain-Barre syndrome is a rare autoimmune condition that affects approximately 100,000 people worldwide each year, with nearly 1 in 78,000 people diagnosed with GBS annually. It is most commonly found in people between the ages of 30 and 50. This disorder occurs when the immune system mistakenly attacks the peripheral nervous system, leading to muscle weakness, numbness, and, in severe cases, paralysis. Although the exact cause of GBS remains unknown,
Group B Streptococcus GBS Diagnosis Market Industry Trends, Size, and Expansion …
A new Report by CoherentMI Market Reports, titled "Group B Streptococcus GBS Diagnosis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Group B Streptococcus GBS Diagnosis market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The group B streptococcus (GBS) diagnosis market is estimated to be valued at USD 1.58
Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market to Hit USD …
DataIntelo's latest report reveals that the Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market was valued at USD XX billion in 2023 and is projected to grow at a significant CAGR of XX% by 2032. This substantial growth is primarily attributed to the increased global awareness regarding the serious implications of GBS infections. As mentioned in the report, raised consciousness about the severity of GBS infections, particularly among pregnant women
US GBS Market 2023 Share, Size, Key Players, Revenue Analysis | Prudent Markets
The US GBS Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global US GBS market. This report explores all the key factors affecting the growth of the global US GBS market, including
Guillain-Barre Syndrome (GBS) Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "Guillain-Barre Syndrome (GBS) Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly studies
B Streptococcus (GBS) Infection Treatment Market to witness remarkable growth By …
"The new report has been added by qyresearch.com to provide detailed insight into the global B Streptococcus (GBS) Infection Treatment market. The study will help to get a better understanding about the B Streptococcus (GBS) Infection Treatment industry competitors, a channel for the distribution, B Streptococcus (GBS) Infection Treatment growth potential, potentially disruptive trends, B Streptococcus (GBS) Infection Treatment industry product innovations, market size value/volume (regional/country level, B Streptococcus (GBS)